EGFR Resisters Patient Portal

EGFR Resisters "Ask the Experts" Clinical Trials within Uncommon EGFR Alterations in NSCLC. During this educational webinar, oncology experts and patient advocates will discuss the therapeutic landscape of uncommon EGFR alterations within NSCLC as well as current clinical trials aimed at advancing therapeutic options in this space.

WEBINAR

Presenters

Ivy Elkins (Moderator), Jill Feldman (Moderator), Balazs Halmos, MD, Julia Rotow, MD

EGFR Resisters “Ask the Experts”

Clinical Trials within Uncommon EGFR Alterations in NSCLC

Download Handout

Meet the Faculty

Ivy Elkins

Patient Advocate
Co-founder, EGFR Resisters

Jill Feldman

Patient Advocate
Co-founder, EGFR Resisters

Balazs Halmos, MD

Associate Director of Clinical Science and Professor of Oncology
Montefiore Einstein Comprehensive Cancer Center

Julia Rotow, MD

Clinical Director of the Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute

Additional Resources

Your EGFR-positive Lung Cancer Journey

What is EGFR-positive Lung Cancer and How will I Know if I have it?

Treatment Options for EGFR-positive Lung Cancer

What to expect after learning you have EGFR-positive lung cancer

Questions to Ask your Doctor on your EGFR-positive Lung Cancer Journey

Clinical endpoints in oncology - a primer

How to Join a Clinical Trial—Cancer Details Checklist (NIH/NCI)

Made in Collaboration With

Financial Support

Supported by an independent educational grant from Black Diamond Therapeutics.

Need More Info?

If you are a patient looking for more information, please send us a note and our expert team will be in touch!

info@ceconcepts.com 859-260-1717

PO Box 55230
Lexington, Ky 40555

Send a Message

"*" indicates required fields